Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review
Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review
Zeng et al., 2011 | Trop Med Int Health | Systematic Review
Citation
Zeng Linan, Zhang Lingli. Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review. Trop Med Int Health. 2011-Dec;16(12):1474-82. doi:10.1111/j.1365-3156.2011.02871.x
Abstract
OBJECTIVES: To determine the efficacy and safety of zinc supplementary in children, adults and pregnant women with HIV infection. METHODS: We conducted a comprehensive search in Medline, Embase, the Cochrane Library, CBM, VIP and CNKI. Only randomized controlled trials conducted subsequent to the introduction of zinc supplementation were included in this systematic review. Two reviewers assessed and extracted data for analysis. RESULTS: Six trials with a total of 1009 participants were included. The findings in this review suggested a benefit of zinc supplementation in reducing opportunistic infection for both adults and children with HIV infection. In terms of increase in zinc level and CD4 counts, however, only adults with HIV infection benefited. For other outcomes, such as viral load, mortality, mother-to-child transmission of HIV and foetal outcomes, zinc supplementation conferred no benefit over placebo. No adverse event related to zinc supplementation was found in all the included trials. CONCLUSION: Based on the current evidence, zinc supplementation seems to be beneficial in adult patients with HIV infection in some aspects. More research is needed in children and pregnant women. The influence of zinc dose, duration and usage of antiretroviral medicine also requires further investigation.
Key Findings
Six trials with a total of 1009 participants were included. The findings in this review suggested a benefit of zinc supplementation in reducing opportunistic infection for both adults and children with HIV infection. In terms of increase in zinc level and CD4 counts, however, only adults with HIV infection benefited. For other outcomes, such as viral load, mortality, mother-to-child transmission of HIV and foetal outcomes, zinc supplementation conferred no benefit over placebo. No adverse event
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | adult patients |
| Sample Size | 1009 |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- AIDS-Related Opportunistic Infections
- Adult
- CD4 Lymphocyte Count
- Child, Preschool
- Diarrhea
- Dietary Supplements
- Female
- HIV Infections
- Humans
- Infant
- Infectious Disease Transmission, Vertical
- Labyrinth Diseases
- Male
- Middle Aged
- Pneumonia
- Pregnancy
- Pregnancy Complications, Infectious
- Pregnancy Outcome
- Randomized Controlled Trials as Topic
- Respiratory Tract Infections
- Trace Elements
- Treatment Outcome
- Viral Load
- Young Adult
- Zinc
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: zinc-immune
Provenance
- PMID: 21895892
- DOI: 10.1111/j.1365-3156.2011.02871.x
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09